TDB Supports Aodh Lifesciences in Pneumonia Treatment Innovation
The Technology Development Board (TDB) of India has backed Aodh Lifesciences Pvt. Ltd. in developing an Indigenous Antibiotic Nebulization Suspension (AONEUM-04) aimed at treating pneumonia and combating antimicrobial resistance. This innovative technology allows for localized antibiotic delivery through nebulization, enhancing treatment efficacy while minimizing side effects. The project aligns with India's goal of affordable healthcare and has cleared pre-clinical trials, moving towards Phase III clinical trials before commercialization.
Source: Original Link